Dynavax Technologies | 운영 비용

Operating Expenses 변화 날짜
AbbVie USD 11.11B 540M 2023-12
Adma Biologics USD 85.84M 27.26M 2023-12
Amgen USD 6.93B 2.11B 2023-12
AstraZeneca USD 9.54B 578M 2023-09
Biogen USD 2.03B 344.1M 2023-12
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Dynavax Technologies USD 64.09M 311K 2023-12
Gilead Sciences USD 5.5B 1.08B 2023-12
Merck USD 16.56B 6.35B 2023-12
Minerva Neurosciences USD 6.08M 1.56M 2023-09
Nektar Therapeutics USD 69.01M 2.09M 2023-09
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
TG Therapeutics USD 56.46M 5.42M 2023-12
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



Dynavax Technologies 운영 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2024.